20/20 Biolabs, Inc. (AIDX) stock
AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.18−0.02 (-9.45%)
Close on Nov 16, 2026Market cap $2.36MP/E –Yield –
20/20 Biolabs profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -182.8%, against -316.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -182.8% | +134.0 |
| FY2024 | Dec 31, 2024 | -316.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -206.2% | – |
| Q1 FY2026 | Mar 31, 2026 | -615.4% | – |
| Q2 FY2025 | Jun 30, 2025 | -157.2% | – |
| Q1 FY2025 | Mar 31, 2025 | -138.1% | – |
See a number that looks wrong?